Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin.
D000328:Adult; D000336:Aerosols; D000368:Aged; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D001982:Bronchial Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010866:Natamycin / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012130:Respiratory Hypersensitivity / Q000188:drug therapy
D000336:Aerosols; D000935:Antifungal Agents; D010866:Natamycin; D011241:Prednisone